Categories: BioTechDiagnosticsHealthTechService
Investors 4
Mentions in press and media 5
| Date | Title | Description | Source |
| 12.10.2023 | Gencurix Receives Australian Government Approval for Droplex... | SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix, a cancer molecular diagnostics company, ... | en.prnasia... |
| 14.06.2023 | Gencurix Obtains Approval for Companion Diagnostic of Digita... | SEOUL, South Korea, June 14, 2023 /PRNewswire/ -- Gencurix, a leading cancer molecular diagnostics c... | en.prnasia... |
| 07.06.2023 | Gencurix Announces Clinical Research Results At ASCO Demonst... | SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix announced the release of clinical research... | en.prnasia... |
| 05.06.2023 | Gencurix Announces Clinical Research Results At ASCO 2023 De... | SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of ca... | en.prnasia... |
| 10.05.2023 | Gencurix announced Korean and Japanese cancer patients' 15-y... | SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix announced clinical results of its prognosti... | en.prnasia... |
Reviews 0
